German Stroke Registry - Endovascular Treatment (GSR-ET)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03356392 |
Recruitment Status :
Recruiting
First Posted : November 29, 2017
Last Update Posted : January 30, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Acute Ischemic Stroke | Other: telephone call d90 |
Study Type : | Observational [Patient Registry] |
Estimated Enrollment : | 2500 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Target Follow-Up Duration: | 90 Days |
Official Title: | German Stroke Registry - Endovascular Treatment |
Actual Study Start Date : | June 2015 |
Estimated Primary Completion Date : | June 2020 |
Estimated Study Completion Date : | June 2025 |
Group/Cohort | Intervention/treatment |
---|---|
stroke patients
acute stroke patients treated with endovascular treatment combined with thrombolysis or without previous thrombolysis Intervention: telephone call on day 90 to assess the primary outcome (mRs d90)
|
Other: telephone call d90
telephone call on day 90 to assess the primary outcome (mRs d90) |
- modified ranking scale on day (mRs) day 90 [ Time Frame: 90 days ]mRs: modified ranking scale; the scale is a commonly used measurement for the degree of disability or dependence in the daily activities of people who have suffered a stroke; scale range 0-6, with 0 - No symptoms. 1 - No significant disability. Able to carry out all usual activities, despite some symptoms. 2 - Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3 - Moderate disability. Requires some help, but able to walk unassisted. 4 - Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5 - Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6 - Dead. publication: van Swieten J, Koudstaal P, Visser M, Schouten H, et al. (1988). "Interobserver agreement for the assessment of handicap in stroke patients". Stroke. 19 (5): 604-607. doi:10.1161/01.str.19.5.604. PMID 3363593.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Clinical diagnosis of acute ischemic stroke
- Eligible for intravenous thrombolysis (IVT) and IVT initiated within 4.5 hours after stroke onset
- Confirmed diagnosis of persistent occlusion of terminal carotid artery, middle cerebral artery (M1 or M2), or basilar artery consistent with symptoms
- Age >18 years
- Ethic approval in process
Exclusion Criteria:
none

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03356392
Contact: Anna Christina Alegiani, Dr | 0049-15222816679 | a.alegiani@uke.de | |
Contact: Frank Wollenweber, PD Dr. | +49 (0)89 4400 - 46046 | frank.wollenweber@med.uni-muenchen.de |
Germany | |
University Medical Center Hamburg-Eppendorf (UKE) | Recruiting |
Hamburg, Germany, 20251 | |
Contact: Anna Alegiani a.alegiani@uke.de | |
Contact: Götz Thomalla thomalla@uke.de | |
Principal Investigator: Christian Gerloff |
Principal Investigator: | Martin Dichgans, Prof | LMU, Munich, Germany | |
Principal Investigator: | Christian Gerloff, Prof | UKE, Hamburg, Germany |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Universitätsklinikum Hamburg-Eppendorf |
ClinicalTrials.gov Identifier: | NCT03356392 |
Other Study ID Numbers: |
GSR-ET |
First Posted: | November 29, 2017 Key Record Dates |
Last Update Posted: | January 30, 2018 |
Last Verified: | January 2018 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
acute stroke, thrombectomy, endovascular treatment |
Stroke Ischemic Stroke Cerebrovascular Disorders Brain Diseases |
Central Nervous System Diseases Nervous System Diseases Vascular Diseases Cardiovascular Diseases |